{"effective_time":"20221105","id":"d96809f2-f942-4f6d-92b9-0a23ec84226d","openfda":{"application_number":["ANDA215037"],"brand_name":["Nelarabine"],"generic_name":["NELARABINE"],"is_original_packager":[true],"manufacturer_name":["Zydus Lifesciences Limited"],"nui":["N0000000233","N0000175595"],"package_ndc":["70771-1685-1","70771-1685-8"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"product_ndc":["70771-1685"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"rxcui":["603566"],"spl_id":["d96809f2-f942-4f6d-92b9-0a23ec84226d"],"spl_set_id":["877b69a0-0899-455d-926e-f5a7478c31f8"],"substance_name":["NELARABINE"],"unii":["60158CV180"]},"package_label_principal_display_panel":["PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1685-1 Nelarabine Injection 250 mg/5 mL (5 mg/mL) 50 mL Single-Dose Vial For Intravenous Infusion Only Rx Only NDC 70771-1685-1 Nelarabine Injection 250 mg/5 mL (5 mg/mL) 50 mL Single-Dose Vial Carton For Intravenous Infusion Only Rx Only vial label"],"set_id":"877b69a0-0899-455d-926e-f5a7478c31f8","spl_product_data_elements":["Nelarabine Nelarabine NELARABINE NELARABINE HYDROCHLORIC ACID SODIUM CHLORIDE SODIUM HYDROXIDE WATER"],"spl_unclassified_section":["."],"version":"2"}